Claim: Elon Musk is planning to purchase $50 billion worth of XRP at $600.37 per token.
Rating: False
Where Did the Rumor Begin?
The claim originated from a now-deleted post by a user named “CryptoGeek” on X (formerly Twitter). The post alleged that Elon Musk was moving away from Dogecoin and preparing to invest heavily in Ripple’s XRP — sparking widespread excitement in crypto forums, Telegram groups, and social media.
Why the Rumor Doesn’t Hold Up
Despite the viral traction, there is no credible evidence supporting this claim:
- No official announcement from Elon Musk
- No confirmation from Tesla, SpaceX, or X
- No statement from Ripple Labs
- No blockchain data indicating a large XRP purchase
- No insider reports or legitimate media coverage
Moreover, the claimed price of $600.37 per XRP is extremely unrealistic. As of now, XRP is trading at just around $2.14, and such a buyout would imply a market cap multiple times larger than the current one — an economic impossibility without moving the entire market.
XRP Market Data (At Time of Writing)
- Current Price: ~$2.14
- 24-Hour Range: $2.09 – $2.20
- Price Change: -0.02%
There’s no unusual spike or trading volume to suggest a mega purchase by a high-profile figure like Musk.
Why You Should Be Skeptical of Crypto Rumors
The crypto world is prone to FOMO-driven misinformation. Here’s how to stay safe:
Verify with credible sources
Look for blockchain evidence or filings
Watch official statements from involved parties
Observe real-time price movement
Avoid making decisions based on social media alone
Final Verdict: Completely False
There is zero proof that Elon Musk is buying $50 billion in XRP. Neither Musk nor any of his companies have made any such moves, and the numbers being circulated do not match XRP’s real-world economics.
Until Elon Musk directly confirms involvement with XRP, treat all such rumors as misinformation.
Stay Smart. Stay Vigilant.
Always base your crypto decisions on facts, not fabricated hype. For accurate news and updates, stick to trusted platforms and cross-check viral claims.